Literature DB >> 23319291

Cryptic residual GALT activity is a potential modifier of scholastic outcome in school age children with classic galactosemia.

Emily L Ryan1, Mary Ellen Lynch, Elles Taddeo, Tyler J Gleason, Michael P Epstein, Judith L Fridovich-Keil.   

Abstract

Classic galactosemia is a potentially lethal disorder that results from profound deficiency of galactose-1-phosphate uridylyltransferase (GALT), the second enzyme in the Leloir pathway of galactose metabolism. Although early diagnosis and rigorous dietary restriction of galactose prevent or resolve the potentially lethal acute symptoms, patients are at markedly increased risk of long-term complications including significant cognitive, speech, and behavioral difficulties, among other problems. The mechanisms that underlie these long-term complications remain unclear, as do the factors that modify their severity. Here we explored the scholastic and behavioral outcomes experienced by a cohort of 54 school age children with classic galactosemia. Data collected included survey responses from parents and teachers, school records including standardized test scores, and GALT genotype data used to estimate predicted residual GALT activity based on a yeast expression system. As expected, many but not all of the children in our study demonstrated speech, scholastic, and behavioral difficulties. Perhaps most striking, we found that predicted cryptic residual GALT activity, often below the threshold of detection of clinical assays, appeared to modify scholastic outcome. These data raise the intriguing possibility that cryptic GALT activity might also influence the severity of other long-term complications in classic galactosemia.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23319291      PMCID: PMC3657299          DOI: 10.1007/s10545-012-9575-x

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  45 in total

Review 1.  Galactosaemia and allelic variation at the galactose-1-phosphate uridyltransferase gene: a complex relationship between genotype and phenotype.

Authors:  L A Tyfield
Journal:  Eur J Pediatr       Date:  2000-12       Impact factor: 3.183

Review 2.  The Child Behavior Checklist and related forms for assessing behavioral/emotional problems and competencies.

Authors:  T M Achenbach; T M Ruffle
Journal:  Pediatr Rev       Date:  2000-08

3.  Working memory, attention, inhibition, and their relation to adaptive functioning and behavioral/emotional symptoms in school-aged children.

Authors:  Virve Vuontela; Synnöve Carlson; Anna-Maria Troberg; Tuija Fontell; Petteri Simola; Suvi Saarinen; Eeva T Aronen
Journal:  Child Psychiatry Hum Dev       Date:  2013-02

4.  Relationship between genotype, activity, and galactose sensitivity in yeast expressing patient alleles of human galactose-1-phosphate uridylyltransferase.

Authors:  K Riehman; C Crews; J L Fridovich-Keil
Journal:  J Biol Chem       Date:  2001-01-04       Impact factor: 5.157

5.  Advances in empirically based assessment: revised cross-informant syndromes and new DSM-oriented scales for the CBCL, YSR, and TRF: comment on Lengua, Sadowksi, Friedrich, and Fischer (2001).

Authors:  T M Achenbach; L Dumenci
Journal:  J Consult Clin Psychol       Date:  2001-08

6.  Structure-function analyses of a common mutation in blacks with transferase-deficiency galactosemia.

Authors:  K Lai; L J Elsas
Journal:  Mol Genet Metab       Date:  2001 Sep-Oct       Impact factor: 4.797

7.  The classification of children's psychiatric symptoms: a factor-analytic study.

Authors:  T M Achenbach
Journal:  Psychol Monogr       Date:  1966

8.  Cognitive strengths and weaknesses in children and adolescents homozygous for the galactosemia Q188R mutation: a descriptive study.

Authors:  Kevin M Antshel; Ingrid O Epstein; Susan E Waisbren
Journal:  Neuropsychology       Date:  2004-10       Impact factor: 3.295

9.  Impact of patient mutations on heterodimer formation and function in human galactose-1-P uridylyltransferase.

Authors:  Nicole C Christacos; Judith L Fridovich-Keil
Journal:  Mol Genet Metab       Date:  2002-08       Impact factor: 4.797

10.  The clinical and molecular spectrum of galactosemia in patients from the Cape Town region of South Africa.

Authors:  Howard Henderson; Felicity Leisegang; Ruth Brown; Brian Eley
Journal:  BMC Pediatr       Date:  2002-09-02       Impact factor: 2.125

View more
  12 in total

1.  Developmental Outcomes of School-Age Children with Duarte Galactosemia: A Pilot Study.

Authors:  Mary Ellen Lynch; Nancy L Potter; Claire D Coles; Judith L Fridovich-Keil
Journal:  JIMD Rep       Date:  2015-02-15

2.  Rigor of non-dairy galactose restriction in early childhood, measured by retrospective survey, does not associate with severity of five long-term outcomes quantified in 231 children and adults with classic galactosemia.

Authors:  Allison B Frederick; David J Cutler; Judith L Fridovich-Keil
Journal:  J Inherit Metab Dis       Date:  2017-07-10       Impact factor: 4.982

3.  Biochemical changes and clinical outcomes in 34 patients with classic galactosemia.

Authors:  Tatiana Yuzyuk; Krista Viau; Ashley Andrews; Marzia Pasquali; Nicola Longo
Journal:  J Inherit Metab Dis       Date:  2018-01-19       Impact factor: 4.982

Review 4.  Drosophila melanogaster Models of Galactosemia.

Authors:  J M I Daenzer; J L Fridovich-Keil
Journal:  Curr Top Dev Biol       Date:  2016-08-03       Impact factor: 4.897

5.  Misfolding of galactose 1-phosphate uridylyltransferase can result in type I galactosemia.

Authors:  Thomas J McCorvie; Tyler J Gleason; Judith L Fridovich-Keil; David J Timson
Journal:  Biochim Biophys Acta       Date:  2013-04-11

6.  Gastrointestinal Health in Classic Galactosemia.

Authors:  Kelly A Shaw; Jennifer G Mulle; Michael P Epstein; Judith L Fridovich-Keil
Journal:  JIMD Rep       Date:  2016-07-01

7.  Modifiers of ovarian function in girls and women with classic galactosemia.

Authors:  Jessica B Spencer; Jennifer R Badik; Emily L Ryan; Tyler J Gleason; K Alaine Broadaway; Michael P Epstein; Judith L Fridovich-Keil
Journal:  J Clin Endocrinol Metab       Date:  2013-05-20       Impact factor: 5.958

8.  Deficits of facial emotion recognition and visual information processing in adult patients with classical galactosemia.

Authors:  Mirjam Korner; Sonja Kälin; Antoinette Zweifel-Zehnder; Niklaus Fankhauser; Jean-Marc Nuoffer; Matthias Gautschi
Journal:  Orphanet J Rare Dis       Date:  2019-02-26       Impact factor: 4.123

9.  A pilot study of neonatal GALT gene replacement using AAV9 dramatically lowers galactose metabolites in blood, liver, and brain and minimizes cataracts in GALT-null rat pups.

Authors:  Shauna A Rasmussen; Jennifer M I Daenzer; Judith L Fridovich-Keil
Journal:  J Inherit Metab Dis       Date:  2020-09-17       Impact factor: 4.982

Review 10.  Early menopause: A hazard to a woman's health.

Authors:  Claudio Hernández-Angeles; Camil Castelo-Branco
Journal:  Indian J Med Res       Date:  2016-04       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.